Sumitomo Pharma America (Formerly Sunovion Pharmaceuticals, INC.)
Research-based pharmaceutical company
Based in MA
🤖
AI Overview
With $1.4M in lobbying spend across 26 quarterly filings, Sumitomo Pharma America (Formerly Sunovion Pharmaceuticals, INC.) is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2024.
$1.4M
Total Spend
7
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $150K |
| 2019 | $160K |
| 2020 | $220K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $300K |
| 2024 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy
- •Issues related to inclusion of prescription drugs within Essential Health Benefit and mental health coverage expansion
- •Issues related to drug pricing and six protected classes
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.